ACCEL Lite: Evaluating the 2025 AHA/ACC High Blood Pressure Guideline
The 2025 High Blood Pressure Guideline introduces key updates to the 2017 recommendations, reflecting the evolving understanding of hypertension and its long‑term impact on patient health. This update emphasizes evidence‑based strategies for diagnosis and management, highlighting the importance of standardized guidelines in improving outcomes. Key takeaways include refined treatment thresholds, enhanced risk‑stratification approaches, and clearer direction for individualized patient care. Looking ahead, the guideline underscores a forward‑thinking approach that integrates emerging research to support more proactive hypertension management.
In this interview, Clyde W. Yancy MD, MACC and Daniel W. Jones, MD discuss the 2025 AHA/ACC High Blood Pressure Guideline.
Related References:
- Writing Committee Members*, Jones DW, Ferdinand KC, et al. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Hypertension. 2025;82(10):e212-e316. doi:10.1161/HYP.0000000000000249
Clinical Topics: Heart Failure and Cardiomyopathies, Acute Heart Failure, Prevention
Keywords: AHA25, ACCELLite, Heart Failure, Blood Pressure